Comparing two strengths of MRI scanner for prostate cancer diagnosis
Compares two MRI scan strengths to see how well each finds prostate cancer in adults.
Plain-language title generated from the registry record
Registry title: Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer
Key facts
- Where
- Hefei, ChinaSee the site
Where in China
- Department of Urology, The First Affiliated Hospital of USTCHefei, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Anhui Provincial Hospital
- Trial code
- NCT06612047
- Record updated
- 11 February 2025
- Original description
The goal of this observational study is to compare 5.0T and 3.0T biparametric magnetic resonance imaging in the diagnosis of prostate cancer. The main aims of this study are:Read full original descriptionShow less
Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer: A Prospective, Single Center and Paired-design Diagnostic Study
The goal of this observational study is to compare 5.0T and 3.0T biparametric magnetic resonance imaging in the diagnosis of prostate cancer. The main aims of this study are:
* Compare the diagnostic efficacy of 5.0TbpMRI and 3.0TbpMRI for prostate cancer. Preliminarily evaluate the value of 5.0TbpMRI in diagnosing prostate cancer. * Compare and analyze the accuracy of 5.0TbpMRI and 3.0TbpMRI in determining the T stage of prostate cancer. Preliminary evaluation of the value of 5.0TbpMRI in determining the tumor stage of prostate cancer.
The data of participants was collected prospectively.
Inclusion: The patient has at least one indication for prostate biopsy (Chinese expert consensus on prostate biopsy (2022 edition) ); The primary prostate cancer has no other cancer history; The 3.0TbpMRI examination was completed, and the images were clear and accessible; The 5.0TbpMRI examination was further completed, and the images were clear and accessible; The patient fully understands the relevant content of the study and voluntarily signs the informed consent.
Exclusion: The patient has undergone other prostatic surgery in the past; The patient has contraindications to MRI examination, such as metal plates and heart stents in the body; The patient does not have an indication for prostate biopsy or refuses biopsy; The patient has contraindications to prostate biopsy; 3.0T MRI considers that the patient has multiple lymph node or bone metastases; The patient is unable to cooperate, has communication barriers, or refuses to sign the informed consent form.